Walvax Biotechnology Co., Ltd. announced that at its AGM held on 12 April 2022, the shareholders approved the 2021 profit distribution plan as cash dividend/10 shares (tax included): CNY 0.27000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.25 CNY | -0.28% | +0.21% | -39.39% |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
Apr. 03 | Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.39% | 3.16B | |
-2.68% | 85.68B | |
+4.08% | 41.4B | |
-25.03% | 28.22B | |
+54.31% | 24.64B | |
-4.67% | 16.98B | |
-42.09% | 13.29B | |
-17.36% | 11.66B | |
-12.10% | 11.65B | |
+0.75% | 8.18B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology Co., Ltd. Approves Cash Dividend for 2021